ArticleOncotarget2016

MicroRNA-mediated epigenetic targeting of Survivin significantly enhances the antitumor activity of paclitaxel against non-small cell lung cancer.

Shuiliang Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.